IL1B and familial dilated cardiomyopathy: Recent studies have revealed that BBR significantly improved DCM by inhibiting IL-1β secretion and GSDMD expression at the post-transcriptional level by activating its promoter (−1000/−500) to upregulate miR-18a-3p expression [127].